Physician profile
Igor Gavrilyuk
NPI 1982732277
$10,696.12
in general payments reported to CMS, 2019-2025
59 companies · $1,683 in 2025
The $1,683 reported for 2025 was more than what 92% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,069 · 2020: $1,145 · 2021: $1,763 · 2022: $1,835 · 2023: $1,753 · 2024: $1,449 · 2025: $1,683.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,885.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,884.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $928.28 | 2019-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals Lp | $915.05 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novartis Pharmaceuticals Corporation | $809.74 | 2019-2025 | |
| Lilly USA, LLC | $758.52 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $711.95 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $690.24 | 2019-2025 | |
| Pfizer INC. | $569.91 | 2019-2025 | |
| Gilead Sciences, INC. | $518.48 | 2019-2025 | Yeztugo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $399.38 | 2020-2025 | Jardiance, Tradjenta, Synjardy |
| Amgen INC. | $357.87 | 2019-2025 | Repatha, Otezla, Evenity |
| Merck Sharp & Dohme LLC | $340.50 | 2019-2024 | Verquvo, Belsomra |
| Janssen Pharmaceuticals, INC | $312.60 | 2019-2025 | Spravato |
| Amarin Pharma, INC. | $296.75 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $248.46 | 2023-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Nestle Healthcare Nutrition INC. | $244.55 | 2020-2023 |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $237.43 | 2020-2025 | Nexletol |
| Aimmune Therapeutics, INC. | $170.57 | 2024-2025 | Zenpep |
| Allergan, INC. | $147.88 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $140.21 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $137.31 | 2021-2025 | |
| Radius Health, INC. | $121.84 | 2019 | |
| Exact Sciences Corporation | $115.63 | 2023-2025 | Cologuard Collection Kit |
| Sanofi Pasteur INC. | $90.09 | 2019-2024 | |
| Nevro Corp. | $88.71 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $86.21 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $77.25 | 2019-2022 | |
| Seqirus USA INC | $77.01 | 2021-2024 | Fluad, Flucelvax, Fluad Quadrivalent |
| Currax Pharmaceuticals LLC | $68.37 | 2021-2023 | Contrave, Nexletol, Nexlizet |
| Vivus LLC | $66.34 | 2021-2024 | Qsymia |
| Abbott Laboratories | $62.99 | 2022-2023 | Octrode, Mitraclip |
| Scilex Pharmaceuticals INC. | $61.29 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $58.25 | 2021-2024 | Linzess |
| Edwards Lifesciences Corporation | $51.95 | 2025 | Sapien 3 Ultra Resilia |
| Almatica Pharma LLC | $47.87 | 2022 | |
| Abiomed | $46.83 | 2024 | Impella |
| Spinal Simplicity, LLC | $46.16 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $45.21 | 2021 | |
| Si-Bone, INC. | $44.75 | 2019-2022 | |
| Hologic Sales and Service, LLC | $42.97 | 2024 | Aptima |
| Astellas Pharma US INC | $39.09 | 2019-2024 | Veozah |
| Antares Pharma, INC. | $38.19 | 2022 | |
| Eisai INC. | $35.34 | 2022 | |
| Idorsia Pharmaceuticals US INC | $30.95 | 2023 | Quviviq |
| Inspire Medical Systems, INC. | $28.77 | 2025 | Inspire |
| Baxter Healthcare | $28.06 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Organogenesis INC. | $25.31 | 2023 | Puraply |
| Teleflex LLC | $24.89 | 2025 | Barrigel |
| Neuronetics, INC. | $23.71 | 2025 | Neurostar Tms Therapy System |
| Axonics, INC. | $23.64 | 2023 | Axonics |
| Alnylam Pharmaceuticals INC. | $20.23 | 2023 | Amvuttra |
| Jazz Pharmaceuticals INC. | $19.28 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $18.64 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $18.14 | 2023 | Inpefa |
| Philips North America LLC | $16.74 | 2024 | (Ck7) Extended Holter |
| Supernus Pharmaceuticals, INC. | $16.46 | 2020 | |
| Recordati_rare_diseases_inc. | $16.16 | 2024 | Isturisa, Signifor Lar |
| Phadia US INC. | $15.26 | 2023 | Immunocap |
| Horizon Therapeutics Plc | $13.45 | 2022 | |
| Sumitomo Pharma America, INC. | $8.41 | 2023 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Igor Gavrilyuk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.